63546 Federal Register / Vol. 60, No. 237 / Monday, December 11, 1995 / Notices

comments relating to the proposed

Consent Decree. Comments should be

addressed to the Assistant Attorney

General for the Environment and

Natural Resources Division, Department

of Justice, Washington, DC 20530, and

should refer to United States v. General

Motors Corporation, DOJ Ref. #90–5–2–

1–2011 and 2011A.

The proposed Consent Decree may be

examined at the Office of the United

States Attorney, Judiciary Center Bldg.,

555 Fourth St. NW., Washington, DC

20001; at the Environmental Protection

Agency Library, Reference Desk, Room

2904, 401 M Street SW., Washington,

DC 20460; and at the Consent Decree

Library, 1120 G Street NW., 4th Floor,

Washington, DC 20005, 202–624–0892.

A copy of the proposed Consent Decree

may be obtained in person or by mail

from the Consent Decree Library, 1120

G Street NW., 4th Floor, Washington,

DC 20005. In requesting a copy, please

refer to the referenced case and enclose

a check in the amount of $18.75 (25

cents per page reproduction costs),

payable to the Consent Decree Library.

Joel M. Gross,

Chief, Environmental Enforcement Section.

[FR Doc. 95–30055 Filed 12–8–95; 8:45 am]

BILLING CODE 4410–01–M

OFFICE OF NATIONAL DRUG

CONTROL POLICY

National Consultation on Drug Control

AGENCY: Office of National Drug Control

Policy.

ACTION: The Office of National Drug

Control Policy (ONDCP) is requesting an

emergency review under the Paperwork

Reduction Act. This is because ONDCP

is required by law to deliver the 1996

National Drug Control Strategy and

Budget document to the Congress in

February, 1996, and the subject

consultation is critical to the

development of that Strategy.

SUMMARY: The Office of National Drug

Control Policy, Executive Office of the

President, in carrying out its

responsibilities under the Paperwork

Reduction Act (44 U.S.C. Chapter 35, 5

CFR 1320 {53 FR 16618, May 10,

1988}), is submitting a request to

conduct a National Consultation on

Drug Control, entitled ‘‘Consult With

America.’’ The ONDCP consultation

survey instrument will be used to assess

public opinion regarding perceptions of

the use and impact of illicit drugs; the

effectiveness of prevention, intervention

and treatment programs; and level of

public support for specific drug control

actions. A telephone survey of a random

sample of adults 18 years of age and

older will be conducted.

DATES: ONDCP has requested an

emergency review of this submission

under the Paperwork Reduction Act;

this Office of Management and Budget

(OMB) review has been requested to be

completed by December 8, 1995.

FOR FURTHER INFORMATION CONTACT:

Comments and questions regarding the

National Survey on Drug Control should

be directed to Mr. N. Ross Deck, Senior

Policy Analyst, Office of National Drug

Control Policy, Executive Office of the

President, 750 17th Street NW.,

Washington, DC 20500, (202) 395–6736.

Any member of the public who wants to

comment on the information collection

request which has been submitted to

OMB should advise Mr. Deck of this

intent at the earliest possible date.

Average Burden Hours/Minutes per

Response: 12 Minutes.

Frequency of Response: One time data

collection.

Number of Respondents: 2,000.

Total Annual Burden Hours: 400.

Total Annual Response: 2,000.

Affected Public: Non-institutional

adult (18 years of age or older)

population residing in the U.S. at the

household level.

Respondents Obligation to Replay:

The survey is voluntary.

SUPPLEMENTARY INFORMATION: None.

Signed at Washington, DC, this 1st day of

December, 1995.

N. Ross Deck,

Senior Policy Analyst.

[FR Doc. 95–30030 Filed 12–8–95; 8:45 am]

BILLING CODE 3180–02–P

NUCLEAR REGULATORY

COMMISSION

[Docket No. 50–440]

Cleveland Electric Illuminating

Company, Centerior Service Company,

Duquesne Light Company, Ohio

Edison Company, Pennsylvania Power

Company, Toledo Edison Company

(Perry Nuclear Power Plant, Unit 1);

Exemption

I

Cleveland Electric Illuminating

Company, (the licensee) is the holder of

Facility Operating License No. NPF–58,

which authorizes operation of the Perry

Nuclear Power Plant, Unit 1 (PNPP).

The operating license provides, among

other things, that the licensee is subject

to all rules, regulations, and orders of

the Commission now and hereafter in

effect.

The facility consists of a single boiling

water reactor located at the licensee’s

site in Lake County, Ohio.

II

Containment leak rate testing is

necessary to demonstrate that the

measured leak rate is within the

acceptance criteria cited in the licensing

design basis. Periodic testing of the

overall containment structure along

with separate leak testing of the

penetrations provides assurance that

post-accident radiological consequences

will be within the limits of 10 CFR Part

100. The Commission’s requirements

regarding leak rate testing are found in

Appendix J to 10 CFR Part 50.

In its letter dated October 21, 1994,

the licensee applied for partial

exemptions from the Commission’s

regulations. The subject exemptions,

which are from the requirements in

Appendix J, Option A, to 10 CFR Part

50, include:

• Section III.A.5(b)(2) states that the

measured leakage from the containment

integrated leak rate (Type A) test (Lam)

shall be less than 75% of the maximum

allowable leakage rate (0.75 La).

• Sections III.B.3 and III.C.3 require

that the combined leakage of valves and

penetrations subject to Type B and C

local leak rate testing be less than 0.6

times the maximum allowable leakage

rate (0.6 La).

• Section III.A.1(d) requires that all

fluid systems that would be open to

containment following post-accident

conditions, be vented and drained prior

to conducting the containment

integrated leak rate test.

• Section III.D.1(a) states that the

third Type A test of each 10-year

interval be conducted when the plant is

shut down for the 10-year plant

inservice inspection.

• Section III.D.3 states that Type C

tests shall be performed during each

reactor shutdown for refueling but in no

case at intervals greater than 2 years.

Type C tests are tests intended to

measure containment isolation valve

leakage rates.

III

Section III.A.5(b)(2) states that the

measured leakage from the containment

integrated leak rate (Type A) test (Lam)

shall be less than 75% of the maximum

allowable leakage rate (0.75 La). The

licensee proposes to exempt main steam

line isolation valve leakage from Type A

test results and consider leakage from

the main steam lines separately.

Sections III.B.3 and III.C.3 require that

the combined leakage of valves and

penetrations subject to Type B and C

local leak rate testing be less than 0.6